562TiP A phase Ib dose-escalation study of ZN-c3, a WEE1 inhibitor, in combination with chemotherapy in patients with platinum-resistant or -refractory ovarian, peritoneal, or fallopian tube cancer

Autor: Fu, S., Pasic, A., Richardson, G., Vranjes, Z.J., Meniawy, T., de Jong, P.R., Donate, F., Samatar, A.A., Rodriguez, J., Pultar, P., Voliotis, D.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S618-S618
Databáze: ScienceDirect